KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacific Biosciences Of California (PACB) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Pacific Biosciences Of California (PACB) over the last 15 years, with Q3 2025 value amounting to 0.89%.

  • Pacific Biosciences Of California's Return on Capital Employed fell 6000.0% to 0.89% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.89%, marking a year-over-year decrease of 6000.0%. This contributed to the annual value of 0.33% for FY2024, which is 1300.0% down from last year.
  • Latest data reveals that Pacific Biosciences Of California reported Return on Capital Employed of 0.89% as of Q3 2025, which was down 6000.0% from 0.88% recorded in Q2 2025.
  • In the past 5 years, Pacific Biosciences Of California's Return on Capital Employed registered a high of 0.1% during Q2 2021, and its lowest value of 0.89% during Q3 2025.
  • Its 5-year average for Return on Capital Employed is 0.3%, with a median of 0.2% in 2024.
  • In the last 5 years, Pacific Biosciences Of California's Return on Capital Employed soared by 16000bps in 2021 and then tumbled by -6300bps in 2025.
  • Over the past 5 years, Pacific Biosciences Of California's Return on Capital Employed (Quarter) stood at 0.11% in 2021, then plummeted by -86bps to 0.2% in 2022, then grew by 4bps to 0.19% in 2023, then tumbled by -90bps to 0.37% in 2024, then crashed by -141bps to 0.89% in 2025.
  • Its Return on Capital Employed stands at 0.89% for Q3 2025, versus 0.88% for Q2 2025 and 0.83% for Q1 2025.